S100A8 and myeloproliferative disorder: CYBB/NOX2 that was upregulated in all subtypes is a super-oxide-generating enzyme that interacts with S100A8/9 and might contribute to elevated ROS levels in MPN patients promoting the acquisition of additional mutations and the stabilization of HIF-1α [60, 66].